目的:探讨前列倍喜胶囊加а受体阻滞剂(naftopidil)治疗慢性前列腺炎/慢性骨盆疼痛综合征(CP/CPPS)的临床疗效。方法:按前列腺炎诊断治疗指南标准[1]选出符合CP/CPPS患者96例,采用随机双盲对照,分为治疗组和对照组。治疗组(56例)服用前列倍喜胶囊加а-受体阻滞剂;对照组(40例)服用а-受体阻滞剂加安慰剂;疗程为6周。配合前列腺按摩,每周一次,然后观察其疗效。结果:治疗组56例患者,显效16例,有效34例,无效6例。总有效率89.3%(50/56);对照组40例患者,显效4例,有效24例,无效12例。总有效率70.0%(28/40)。两组疗效比较有统计学意义(P lt;0.05);治疗组治疗前后NIH-CPSI各项指标比较有显著性统计学意义(P lt;0.01);对照组治疗前后NIH-CPSI各项指标比较有统计学意义(P lt;0.05),两组治疗前后NIH-CPSI比较有统计学意义(P lt;0.05)。结论:前列倍喜胶囊加а-受体阻滞剂联合治疗CP/CPPS安全有效。
Citation: QIN Su,SHAN Ming,ZENG TieBing,et al.. Clinical Observation on the Treatment of Chronic Prostatitis and CPPS by Prostatic Bashu Capsula and Naftopidil. West China Medical Journal, 2009, 24(6): 1395-1397. doi: Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved